This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2
Signal Transduction and Targeted Therapy Open Access 07 April 2023
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Leonard, W. J., Lin, J. X. & O’Shea, J. J. Immunity. https://doi.org/10.1016/j.immuni.2019.03.028 (2009).
Zhou, X. et al. Nat. Immunol. 20, 879–889 (2019).
Rautela, J. & Huntington, N. D. Curr. Opin. Immunol. 44, 1–6 (2017).
Waldmann, T. A. & Tagaya, Y. Annu. Rev. Immunol. 17, 19–49 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huggins, M.A., Hamilton, S.E. Deubiquitinase Otub1 negatively regulates IL-15 signaling in CD8 T cells and NK cells. Cell Mol Immunol 16, 846–847 (2019). https://doi.org/10.1038/s41423-019-0283-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-019-0283-4
This article is cited by
-
OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2
Signal Transduction and Targeted Therapy (2023)